MetaCap

Anteris Technologies Global (AVR) vs OrthoPediatrics (KIDS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

Anteris Technologies Global (AVR) has outperformed OrthoPediatrics (KIDS) over the past year, gaining 38.4% versus a gain of 20.6%. Anteris Technologies Global is the larger company by market cap ($659.8 million vs $565.3 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVR+38.45%KIDS+20.61%
+124%+43%-38%
Oct 9, 20251 yearOct 9, 2026
AVR+20.89%KIDS-2.12%
+90%+13%-63%
Dec 9, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVR versus KIDS key metrics
MetricAVRKIDS
Share price$6.77$21.65
Market cap$659.79M$565.28M
1-day change+2.11%-0.51%
YTD return+35.67%+21.90%
1-year return+38.45%+20.61%
5-year return—-65.60%
EPS (TTM)$-1.99$-1.68
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.06$26.74
52-week low$3.30$14.42
Distance from 52-week high-38.76%-19.04%
Analyst consensusstrong_buynone
Avg. price target upside+106.79%+25.73%
Average volume938.88K211.79K
Shares outstanding97.46M26.11M
Employees174602
SectorHealth CareHealthcare
IndustryIndustrial SpecialtiesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • AVR has outperformed KIDS by 17.8 percentage points over the past year.
  • The two companies sit in different sectors: Anteris Technologies Global in Health Care and OrthoPediatrics in Healthcare.

About Anteris Technologies Global

AVR stock →

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.

Health Care · Industrial Specialties · 174 employees

About OrthoPediatrics

KIDS stock →

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.

Healthcare · Medical Devices · 602 employees

AVR vs KIDS FAQ

Which is bigger, Anteris Technologies Global or OrthoPediatrics?

Anteris Technologies Global (AVR) is larger, with a market capitalization of $659.79M compared with $565.28M for OrthoPediatrics (KIDS).

Which stock has performed better over the past year, AVR or KIDS?

AVR returned +38.45% over the past 12 months, compared with +20.61% for KIDS (price return, excluding dividends). Past performance does not predict future results.

Are Anteris Technologies Global and OrthoPediatrics in the same industry?

No. Anteris Technologies Global is in the Health Care sector, while OrthoPediatrics is in Healthcare.

More comparisons